GlaxoSmithKline Pharma Q2 net down 14.56% to Rs 98.29 crore

Tags: Companies
GlaxoSmithKline Pharmaceuticals today reported 14.56 per cent decline in net profit to Rs 98.29 crore for the quarter ended June 30 as the company continued to be impacted by the revamped price control order.

The company had reported a net profit of Rs 115.04 crore during the same period last year.

Net sales of the company increased 2.84 per cent to Rs 654.96 crore for the second quarter as compared to Rs 636.86 crore in the same period a year ago, GlaxoSmithKline Pharmaceuticals said in a BSE filing.

The company follows January-December financial year.

"The quarter continued to see the impact of the base effect of differential pricing cuts due to price control order, extending coverage to the National List of Essential Medicines (NLEM)," the company said.

Last year, Department of Pharmaceuticals had notified the Drugs (Prices Control) Order 2013 under which prices of 348 medicines in the NLEM have been brought under price control, thus replacing an earlier order of 1995 that regulated prices of only 74 bulk drugs.

Shares of GlaxoSmithKline Pharma were trading 0.84 per cent down at Rs 2,473.85 apiece during afternoon trade on the BSE.

EDITORIAL OF THE DAY

  • America, put an end to this mindless terror against Indian professionals

    Racial slurs, hate crimes and the daylight murder of an Indian technology professional in the US have just moved up the number of serious issues confr

FC NEWSLETTER

Stay informed on our latest news!

TODAY'S COLUMNS

Sandeep Bamzai

Disequilibrium: Pawn to king four

Sir Conrad Corfield, heavy hitter of the British Political Department ...

Susan Visvanathan

The problem called JNU

Reservation is a word that some administrators and intellectuals find ...

Kuruvilla Pandikattu

We are all wired for empathy

Today the world is all abuzz about the science of ...